Long-term outcome of percutaneous transluminal renal angioplasty (PTRA) versus PTRA with stenting (PTRAS) in transplant renal artery stenosis

Endovascular treatment is standard of care for transplant renal artery stenosis (TRAS). No study has evaluated long-term outcomes compared between percutaneous transluminal renal angioplasty (PTRA) and PTRA with stenting (PTRAS). Accordingly, this study aimed to investigate the 1-year clinical succe...

Full description

Saved in:
Bibliographic Details
Published inBMC cardiovascular disorders Vol. 21; no. 1; p. 212
Main Authors Wongpraparut, Nattawut, Chaipruckmalakarn, Thunyarat, Tongdee, Thongtum, Jaspttananon, Archan, Vongwiwatana, Attapong, Premasathian, Nalinee, Anusonadisai, Kawin, Pongakasira, Rungtiwa
Format Journal Article
LanguageEnglish
Published England BioMed Central 26.04.2021
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Endovascular treatment is standard of care for transplant renal artery stenosis (TRAS). No study has evaluated long-term outcomes compared between percutaneous transluminal renal angioplasty (PTRA) and PTRA with stenting (PTRAS). Accordingly, this study aimed to investigate the 1-year clinical success, and short- and long-term event-free survival between PTRA and PTRAS in patients diagnosed with TRAS at Thailand's largest national tertiary referral center. This single-center retrospective study included kidney transplant patients treated for TRAS during January 2001 to June 2019. Clinical success was defined as (1) increase in estimated glomerular filtration rate (eGFR) > 15%, or (2) reduction in mean arterial pressure (MAP) > 15% with no decrease in antihypertensive medication, or no reduction in MAP or reduction in MAP < 15% with decrease in antihypertensive medication. Incidence of kidney transplant graft failure and transplant renal artery stenosis were also collected. Sixty-five cases of TRAS were identified from 1072 patients who underwent kidney transplantation. The majority (98.5%) had end-to-side anastomosis technique. Thirty-four patients had PTRA, while 31 patients had PTRAS. One-year clinical success according to renal outcome and BP reduction was 78.5% and 49.2%, respectively. Both renal outcome (79.4% vs. 77.4%, p = 0.845) and BP reduction (40.6% vs. 58.1%, p = 0.166) at 1 year were similar between the PTRA and PTRAS groups. Compared between PTRA and PTRAS, event-free survival for composite of kidney transplant graft failure or transplant renal artery restenosis was significantly higher for PTRAS at 1 year (82.4% vs. 100%, p = 0.025), but not significantly different at 10 years (73.5% vs. 71%, p = 0.818). We demonstrated the 1-year clinical success, and short- and long-term event-free survival between PTRA and PTRAS in TRAS patients. One-year clinical success was found to be similar between groups. Event-free survival for composite of kidney transplant graft failure or transplant renal artery restenosis was significantly higher in PTRAS at 1 year, but similar between groups at 10 years. Trial registration Thai Clinical Trials Registry, TCTR20200626002. Registered 26 June 2020-Retrospectively registered, http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trial search&smenu = fulltext&task = search&task2 = view1&id = 6441.
AbstractList Abstract Background Endovascular treatment is standard of care for transplant renal artery stenosis (TRAS). No study has evaluated long-term outcomes compared between percutaneous transluminal renal angioplasty (PTRA) and PTRA with stenting (PTRAS). Accordingly, this study aimed to investigate the 1-year clinical success, and short- and long-term event-free survival between PTRA and PTRAS in patients diagnosed with TRAS at Thailand’s largest national tertiary referral center. Methods This single-center retrospective study included kidney transplant patients treated for TRAS during January 2001 to June 2019. Clinical success was defined as (1) increase in estimated glomerular filtration rate (eGFR) > 15%, or (2) reduction in mean arterial pressure (MAP) > 15% with no decrease in antihypertensive medication, or no reduction in MAP or reduction in MAP < 15% with decrease in antihypertensive medication. Incidence of kidney transplant graft failure and transplant renal artery stenosis were also collected. Results Sixty-five cases of TRAS were identified from 1072 patients who underwent kidney transplantation. The majority (98.5%) had end-to-side anastomosis technique. Thirty-four patients had PTRA, while 31 patients had PTRAS. One-year clinical success according to renal outcome and BP reduction was 78.5% and 49.2%, respectively. Both renal outcome (79.4% vs. 77.4%, p = 0.845) and BP reduction (40.6% vs. 58.1%, p = 0.166) at 1 year were similar between the PTRA and PTRAS groups. Compared between PTRA and PTRAS, event-free survival for composite of kidney transplant graft failure or transplant renal artery restenosis was significantly higher for PTRAS at 1 year (82.4% vs. 100%, p = 0.025), but not significantly different at 10 years (73.5% vs. 71%, p = 0.818). Conclusions We demonstrated the 1-year clinical success, and short- and long-term event-free survival between PTRA and PTRAS in TRAS patients. One-year clinical success was found to be similar between groups. Event-free survival for composite of kidney transplant graft failure or transplant renal artery restenosis was significantly higher in PTRAS at 1 year, but similar between groups at 10 years. Trial registration Thai Clinical Trials Registry, TCTR20200626002. Registered 26 June 2020—Retrospectively registered, http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trial search&smenu = fulltext&task = search&task2 = view1&id = 6441
Abstract Background Endovascular treatment is standard of care for transplant renal artery stenosis (TRAS). No study has evaluated long-term outcomes compared between percutaneous transluminal renal angioplasty (PTRA) and PTRA with stenting (PTRAS). Accordingly, this study aimed to investigate the 1-year clinical success, and short- and long-term event-free survival between PTRA and PTRAS in patients diagnosed with TRAS at Thailand’s largest national tertiary referral center. Methods This single-center retrospective study included kidney transplant patients treated for TRAS during January 2001 to June 2019. Clinical success was defined as (1) increase in estimated glomerular filtration rate (eGFR) > 15%, or (2) reduction in mean arterial pressure (MAP) > 15% with no decrease in antihypertensive medication, or no reduction in MAP or reduction in MAP < 15% with decrease in antihypertensive medication. Incidence of kidney transplant graft failure and transplant renal artery stenosis were also collected. Results Sixty-five cases of TRAS were identified from 1072 patients who underwent kidney transplantation. The majority (98.5%) had end-to-side anastomosis technique. Thirty-four patients had PTRA, while 31 patients had PTRAS. One-year clinical success according to renal outcome and BP reduction was 78.5% and 49.2%, respectively. Both renal outcome (79.4% vs . 77.4%, p  = 0.845) and BP reduction (40.6% vs. 58.1%, p  = 0.166) at 1 year were similar between the PTRA and PTRAS groups. Compared between PTRA and PTRAS, event-free survival for composite of kidney transplant graft failure or transplant renal artery restenosis was significantly higher for PTRAS at 1 year (82.4% vs. 100%, p  = 0.025), but not significantly different at 10 years (73.5% vs . 71%, p  = 0.818). Conclusions We demonstrated the 1-year clinical success, and short- and long-term event-free survival between PTRA and PTRAS in TRAS patients. One-year clinical success was found to be similar between groups. Event-free survival for composite of kidney transplant graft failure or transplant renal artery restenosis was significantly higher in PTRAS at 1 year, but similar between groups at 10 years. Trial registration Thai Clinical Trials Registry, TCTR20200626002. Registered 26 June 2020—Retrospectively registered, http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trial search&smenu = fulltext&task = search&task2 = view1&id = 6441
Endovascular treatment is standard of care for transplant renal artery stenosis (TRAS). No study has evaluated long-term outcomes compared between percutaneous transluminal renal angioplasty (PTRA) and PTRA with stenting (PTRAS). Accordingly, this study aimed to investigate the 1-year clinical success, and short- and long-term event-free survival between PTRA and PTRAS in patients diagnosed with TRAS at Thailand's largest national tertiary referral center. This single-center retrospective study included kidney transplant patients treated for TRAS during January 2001 to June 2019. Clinical success was defined as (1) increase in estimated glomerular filtration rate (eGFR) > 15%, or (2) reduction in mean arterial pressure (MAP) > 15% with no decrease in antihypertensive medication, or no reduction in MAP or reduction in MAP < 15% with decrease in antihypertensive medication. Incidence of kidney transplant graft failure and transplant renal artery stenosis were also collected. Sixty-five cases of TRAS were identified from 1072 patients who underwent kidney transplantation. The majority (98.5%) had end-to-side anastomosis technique. Thirty-four patients had PTRA, while 31 patients had PTRAS. One-year clinical success according to renal outcome and BP reduction was 78.5% and 49.2%, respectively. Both renal outcome (79.4% vs. 77.4%, p = 0.845) and BP reduction (40.6% vs. 58.1%, p = 0.166) at 1 year were similar between the PTRA and PTRAS groups. Compared between PTRA and PTRAS, event-free survival for composite of kidney transplant graft failure or transplant renal artery restenosis was significantly higher for PTRAS at 1 year (82.4% vs. 100%, p = 0.025), but not significantly different at 10 years (73.5% vs. 71%, p = 0.818). We demonstrated the 1-year clinical success, and short- and long-term event-free survival between PTRA and PTRAS in TRAS patients. One-year clinical success was found to be similar between groups. Event-free survival for composite of kidney transplant graft failure or transplant renal artery restenosis was significantly higher in PTRAS at 1 year, but similar between groups at 10 years. Trial registration Thai Clinical Trials Registry, TCTR20200626002. Registered 26 June 2020-Retrospectively registered, http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trial search&smenu = fulltext&task = search&task2 = view1&id = 6441.
Background Endovascular treatment is standard of care for transplant renal artery stenosis (TRAS). No study has evaluated long-term outcomes compared between percutaneous transluminal renal angioplasty (PTRA) and PTRA with stenting (PTRAS). Accordingly, this study aimed to investigate the 1-year clinical success, and short- and long-term event-free survival between PTRA and PTRAS in patients diagnosed with TRAS at Thailand’s largest national tertiary referral center. Methods This single-center retrospective study included kidney transplant patients treated for TRAS during January 2001 to June 2019. Clinical success was defined as (1) increase in estimated glomerular filtration rate (eGFR) > 15%, or (2) reduction in mean arterial pressure (MAP) > 15% with no decrease in antihypertensive medication, or no reduction in MAP or reduction in MAP < 15% with decrease in antihypertensive medication. Incidence of kidney transplant graft failure and transplant renal artery stenosis were also collected. Results Sixty-five cases of TRAS were identified from 1072 patients who underwent kidney transplantation. The majority (98.5%) had end-to-side anastomosis technique. Thirty-four patients had PTRA, while 31 patients had PTRAS. One-year clinical success according to renal outcome and BP reduction was 78.5% and 49.2%, respectively. Both renal outcome (79.4% vs. 77.4%, p = 0.845) and BP reduction (40.6% vs. 58.1%, p = 0.166) at 1 year were similar between the PTRA and PTRAS groups. Compared between PTRA and PTRAS, event-free survival for composite of kidney transplant graft failure or transplant renal artery restenosis was significantly higher for PTRAS at 1 year (82.4% vs. 100%, p = 0.025), but not significantly different at 10 years (73.5% vs. 71%, p = 0.818). Conclusions We demonstrated the 1-year clinical success, and short- and long-term event-free survival between PTRA and PTRAS in TRAS patients. One-year clinical success was found to be similar between groups. Event-free survival for composite of kidney transplant graft failure or transplant renal artery restenosis was significantly higher in PTRAS at 1 year, but similar between groups at 10 years. Trial registration Thai Clinical Trials Registry, TCTR20200626002. Registered 26 June 2020—Retrospectively registered, http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trial search&smenu = fulltext&task = search&task2 = view1&id = 6441
BACKGROUNDEndovascular treatment is standard of care for transplant renal artery stenosis (TRAS). No study has evaluated long-term outcomes compared between percutaneous transluminal renal angioplasty (PTRA) and PTRA with stenting (PTRAS). Accordingly, this study aimed to investigate the 1-year clinical success, and short- and long-term event-free survival between PTRA and PTRAS in patients diagnosed with TRAS at Thailand's largest national tertiary referral center. METHODSThis single-center retrospective study included kidney transplant patients treated for TRAS during January 2001 to June 2019. Clinical success was defined as (1) increase in estimated glomerular filtration rate (eGFR) > 15%, or (2) reduction in mean arterial pressure (MAP) > 15% with no decrease in antihypertensive medication, or no reduction in MAP or reduction in MAP < 15% with decrease in antihypertensive medication. Incidence of kidney transplant graft failure and transplant renal artery stenosis were also collected. RESULTSSixty-five cases of TRAS were identified from 1072 patients who underwent kidney transplantation. The majority (98.5%) had end-to-side anastomosis technique. Thirty-four patients had PTRA, while 31 patients had PTRAS. One-year clinical success according to renal outcome and BP reduction was 78.5% and 49.2%, respectively. Both renal outcome (79.4% vs. 77.4%, p = 0.845) and BP reduction (40.6% vs. 58.1%, p = 0.166) at 1 year were similar between the PTRA and PTRAS groups. Compared between PTRA and PTRAS, event-free survival for composite of kidney transplant graft failure or transplant renal artery restenosis was significantly higher for PTRAS at 1 year (82.4% vs. 100%, p = 0.025), but not significantly different at 10 years (73.5% vs. 71%, p = 0.818). CONCLUSIONSWe demonstrated the 1-year clinical success, and short- and long-term event-free survival between PTRA and PTRAS in TRAS patients. One-year clinical success was found to be similar between groups. Event-free survival for composite of kidney transplant graft failure or transplant renal artery restenosis was significantly higher in PTRAS at 1 year, but similar between groups at 10 years. Trial registration Thai Clinical Trials Registry, TCTR20200626002. Registered 26 June 2020-Retrospectively registered, http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trial search&smenu = fulltext&task = search&task2 = view1&id = 6441.
ArticleNumber 212
Author Tongdee, Thongtum
Vongwiwatana, Attapong
Anusonadisai, Kawin
Pongakasira, Rungtiwa
Chaipruckmalakarn, Thunyarat
Wongpraparut, Nattawut
Premasathian, Nalinee
Jaspttananon, Archan
Author_xml – sequence: 1
  givenname: Nattawut
  orcidid: 0000-0002-1541-3313
  surname: Wongpraparut
  fullname: Wongpraparut, Nattawut
  email: wongpraparut@yahoo.com
  organization: Division of Cardiology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Wanglang Road, Bangkoknoi, Bangkok, 10700, Thailand. wongpraparut@yahoo.com
– sequence: 2
  givenname: Thunyarat
  surname: Chaipruckmalakarn
  fullname: Chaipruckmalakarn, Thunyarat
  organization: Division of Cardiology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Wanglang Road, Bangkoknoi, Bangkok, 10700, Thailand
– sequence: 3
  givenname: Thongtum
  surname: Tongdee
  fullname: Tongdee, Thongtum
  organization: Interventional Radiology Unit, Department of Radiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
– sequence: 4
  givenname: Archan
  surname: Jaspttananon
  fullname: Jaspttananon, Archan
  organization: Division of Cardiology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Wanglang Road, Bangkoknoi, Bangkok, 10700, Thailand
– sequence: 5
  givenname: Attapong
  surname: Vongwiwatana
  fullname: Vongwiwatana, Attapong
  organization: Division of Nephrology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
– sequence: 6
  givenname: Nalinee
  surname: Premasathian
  fullname: Premasathian, Nalinee
  organization: Division of Nephrology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
– sequence: 7
  givenname: Kawin
  surname: Anusonadisai
  fullname: Anusonadisai, Kawin
  organization: Division of Cardiology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Wanglang Road, Bangkoknoi, Bangkok, 10700, Thailand
– sequence: 8
  givenname: Rungtiwa
  surname: Pongakasira
  fullname: Pongakasira, Rungtiwa
  organization: Her Majesty's Cardiac Center, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33902459$$D View this record in MEDLINE/PubMed
BookMark eNpdkstu1DAUhi1URC_wAixQJDbtImA7cWxvkKoK2kojgaCsLcdzknqU2IPttJqH4J1xJm3VsvD9O_85PvqP0YHzDhB6T_AnQkTzORIqOC0xJXlgwsr6FToiNSclpQ05eLY_RMcxbjAmXGD5Bh1WlcS0ZvII_V1515cJwlj4KRk_QuG7YgvBTEk78FMsUtAuDtNonR6KAPOsXW_9dtAx7YrTHzc_z8-KOwgxw_OhuLfptogJXLKuX4BfZ4V1i1SOc-lRKOTUuz3ro41v0etODxHePawn6Pe3rzcXV-Xq--X1xfmqNLVsUsnAQLsmDVDTUkqNbuoOc8pMo7nUXSO4aFuoMKkNWQPoVhjRsYZhQw1pGKtO0PWiu_Z6o7bBjjrslNdW7S986FWuzJoBFIYuJ2pkzbq5Y7qlxNSmZZziXIXQWevLorWd2hHWJv866OGF6MsXZ29V7--UwJwLSbPA6YNA8H8miEmNNhoYhqX_ijIipJCVlBn9-B-68VPIjZwpKjImKM8UXSgTfIwBuqdiCFazc9TiHJWdo_bOUXUO-vD8G08hj1ap_gHy-cNo
CitedBy_id crossref_primary_10_1093_ndt_gfad095
Cites_doi 10.1097/00007890-199812270-00014
10.1111/j.1440-1797.2007.00801.x
10.1007/s11547-012-0884-8
10.4103/0970-1591.189707
10.1016/j.jacc.2017.09.930
10.1097/01.TP.0000071849.78031.13
10.1148/radiology.219.3.r01jn30663
10.1111/j.1600-6143.2005.01136.x
10.1097/01.RVI.0000141338.62574.F4
10.1111/j.1600-6143.2005.00927.x
10.1097/01.ASN.0000099379.61001.F8
10.1186/s41100-018-0147-x
10.1097/00007890-200101150-00029
10.1111/j.1445-2197.1979.tb06472.x
10.1007/s00270-015-1134-z
10.1159/000242431
10.1155/2011/219109
10.1097/00007890-199601270-00009
10.1016/S0022-5347(01)62051-2
10.3389/fmed.2020.00229
10.1111/nep.12378
10.1080/02841850902718763
10.1097/TXD.0000000000000643
10.1016/j.transproceed.2011.06.049
ContentType Journal Article
Copyright 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2021
Copyright_xml – notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2021
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7QP
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12872-021-02015-4
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
AUTh Library subscriptions: ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
CrossRef
MEDLINE
Publicly Available Content Database
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2261
EndPage 212
ExternalDocumentID oai_doaj_org_article_0ef16e6945f2459ab21c4cb5720ece8a
10_1186_s12872_021_02015_4
33902459
Genre Journal Article
Comparative Study
GeographicLocations Thailand
Bangkok Thailand
GeographicLocations_xml – name: Thailand
– name: Bangkok Thailand
GroupedDBID ---
-A0
0R~
23N
2WC
3V.
53G
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AAWTL
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACRMQ
ADBBV
ADINQ
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C24
C6C
CCPQU
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EBD
EBLON
EBS
ECGQY
ECM
EIF
EMB
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
NPM
O5R
O5S
OK1
P2P
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
UKHRP
W2D
WOQ
WOW
XSB
AAYXX
CITATION
7QP
7XB
8FK
AZQEC
DWQXO
K9.
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c496t-5ecebd16e2cb222ca64f0725c6a79af6878bbe3014c1deeab8c8f5650c2c16553
IEDL.DBID RPM
ISSN 1471-2261
IngestDate Tue Oct 22 15:16:15 EDT 2024
Tue Sep 17 21:26:23 EDT 2024
Fri Oct 25 01:41:18 EDT 2024
Thu Oct 10 18:42:07 EDT 2024
Thu Sep 12 19:34:36 EDT 2024
Sat Sep 28 08:23:38 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Percutaneous transluminal renal angioplasty with stenting (PTRAS)
Transplant renal artery stenosis (TRAS)
Long-term outcome
Percutaneous transluminal renal angioplasty (PTRA)
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c496t-5ecebd16e2cb222ca64f0725c6a79af6878bbe3014c1deeab8c8f5650c2c16553
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-1541-3313
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077892/
PMID 33902459
PQID 2528898827
PQPubID 44077
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_0ef16e6945f2459ab21c4cb5720ece8a
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8077892
proquest_miscellaneous_2518989399
proquest_journals_2528898827
crossref_primary_10_1186_s12872_021_02015_4
pubmed_primary_33902459
PublicationCentury 2000
PublicationDate 2021-04-26
PublicationDateYYYYMMDD 2021-04-26
PublicationDate_xml – month: 04
  year: 2021
  text: 2021-04-26
  day: 26
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC cardiovascular disorders
PublicationTitleAlternate BMC Cardiovasc Disord
PublicationYear 2021
Publisher BioMed Central
BMC
Publisher_xml – name: BioMed Central
– name: BMC
References HS Howe (2015_CR25) 1984; 25
M Marini (2015_CR18) 2011; 43
CC Estrada (2015_CR30) 2017; 3
JM Halimi (2015_CR10) 1999; 161
K Noppakun (2015_CR1) 2015; 20
JR Beecroft (2015_CR14) 2004; 15
W Wong (2015_CR20) 1996; 61
A Voiculescu (2015_CR9) 2005; 5
FP Hurst (2015_CR23) 2009; 30
BF Henning (2015_CR28) 2009; 71
N Wongpraparut (2015_CR29) 2017; 70
2015_CR2
S Gang (2015_CR19) 2009; 2
V Audard (2015_CR7) 2006; 6
KM Chow (2015_CR12) 2007; 12
AT Ngo (2015_CR6) 2015; 38
Y Mochida (2015_CR5) 2018; 4
S Bruno (2015_CR15) 2003; 76
AO Ojo (2015_CR17) 1998; 66
E Tantisattamo (2015_CR26) 2020; 7
KT Woo (2015_CR22) 2008; 49
G Guzzardi (2015_CR8) 2013; 118
M Marques (2015_CR16) 2001; 71
AB Patil (2015_CR21) 2016; 32
S Bruno (2015_CR3) 2004; 15
MD Pozo (2015_CR4) 2012; 32
G Hagen (2015_CR27) 2009; 50
L Polytimi (2015_CR11) 2011; 2011
NH Patel (2015_CR13) 2001; 219
JP Roberts (2015_CR24) 1989; 48
References_xml – volume: 66
  start-page: 1651
  issue: 12
  year: 1998
  ident: 2015_CR17
  publication-title: Transplantation
  doi: 10.1097/00007890-199812270-00014
  contributor:
    fullname: AO Ojo
– volume: 12
  start-page: 406
  issue: 4
  year: 2007
  ident: 2015_CR12
  publication-title: Nephrology (Carlton)
  doi: 10.1111/j.1440-1797.2007.00801.x
  contributor:
    fullname: KM Chow
– volume: 118
  start-page: 826
  issue: 5
  year: 2013
  ident: 2015_CR8
  publication-title: Radiol Med
  doi: 10.1007/s11547-012-0884-8
  contributor:
    fullname: G Guzzardi
– volume: 32
  start-page: 288
  year: 2016
  ident: 2015_CR21
  publication-title: Indian J Urol
  doi: 10.4103/0970-1591.189707
  contributor:
    fullname: AB Patil
– volume: 70
  start-page: B297
  issue: 18 Supplement
  year: 2017
  ident: 2015_CR29
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2017.09.930
  contributor:
    fullname: N Wongpraparut
– volume: 76
  start-page: 147
  issue: 1
  year: 2003
  ident: 2015_CR15
  publication-title: Transplantation
  doi: 10.1097/01.TP.0000071849.78031.13
  contributor:
    fullname: S Bruno
– volume: 32
  start-page: 455
  issue: 4
  year: 2012
  ident: 2015_CR4
  publication-title: Nefrologia
  contributor:
    fullname: MD Pozo
– volume: 219
  start-page: 663
  issue: 3
  year: 2001
  ident: 2015_CR13
  publication-title: Radiology
  doi: 10.1148/radiology.219.3.r01jn30663
  contributor:
    fullname: NH Patel
– volume: 71
  start-page: 543
  year: 2009
  ident: 2015_CR28
  publication-title: Clin Nephrol
  contributor:
    fullname: BF Henning
– volume: 6
  start-page: 95
  issue: 1
  year: 2006
  ident: 2015_CR7
  publication-title: Am J Transplant
  doi: 10.1111/j.1600-6143.2005.01136.x
  contributor:
    fullname: V Audard
– volume: 15
  start-page: 1407
  issue: 12
  year: 2004
  ident: 2015_CR14
  publication-title: J Vasc Interv Radiol
  doi: 10.1097/01.RVI.0000141338.62574.F4
  contributor:
    fullname: JR Beecroft
– volume: 5
  start-page: 1731
  issue: 7
  year: 2005
  ident: 2015_CR9
  publication-title: Am J Transplant
  doi: 10.1111/j.1600-6143.2005.00927.x
  contributor:
    fullname: A Voiculescu
– volume: 15
  start-page: 134
  year: 2004
  ident: 2015_CR3
  publication-title: J Am Soc Nephrol
  doi: 10.1097/01.ASN.0000099379.61001.F8
  contributor:
    fullname: S Bruno
– volume: 4
  start-page: 1
  year: 2018
  ident: 2015_CR5
  publication-title: Renal Replacement Therapy
  doi: 10.1186/s41100-018-0147-x
  contributor:
    fullname: Y Mochida
– volume: 71
  start-page: 164
  issue: 1
  year: 2001
  ident: 2015_CR16
  publication-title: Transplantation
  doi: 10.1097/00007890-200101150-00029
  contributor:
    fullname: M Marques
– volume: 2
  start-page: 122
  year: 2009
  ident: 2015_CR19
  publication-title: Vascular complications following renal transplantation JNRT
  contributor:
    fullname: S Gang
– volume: 49
  start-page: 613
  year: 2008
  ident: 2015_CR22
  publication-title: ANZ J Surg
  doi: 10.1111/j.1445-2197.1979.tb06472.x
  contributor:
    fullname: KT Woo
– volume: 38
  start-page: 1573
  issue: 6
  year: 2015
  ident: 2015_CR6
  publication-title: Cardiovasc Intervent Radiol
  doi: 10.1007/s00270-015-1134-z
  contributor:
    fullname: AT Ngo
– volume: 30
  start-page: 459
  year: 2009
  ident: 2015_CR23
  publication-title: Am J Nephrol
  doi: 10.1159/000242431
  contributor:
    fullname: FP Hurst
– volume: 2011
  start-page: 219109
  year: 2011
  ident: 2015_CR11
  publication-title: J Transplant
  doi: 10.1155/2011/219109
  contributor:
    fullname: L Polytimi
– volume: 61
  start-page: 215
  year: 1996
  ident: 2015_CR20
  publication-title: Transplantation
  doi: 10.1097/00007890-199601270-00009
  contributor:
    fullname: W Wong
– volume: 25
  start-page: 14
  year: 1984
  ident: 2015_CR25
  publication-title: Singapore Med J
  contributor:
    fullname: HS Howe
– volume: 161
  start-page: 28
  issue: 1
  year: 1999
  ident: 2015_CR10
  publication-title: J Urol.
  doi: 10.1016/S0022-5347(01)62051-2
  contributor:
    fullname: JM Halimi
– ident: 2015_CR2
– volume: 48
  start-page: 580
  year: 1989
  ident: 2015_CR24
  publication-title: Transplantation
  contributor:
    fullname: JP Roberts
– volume: 7
  start-page: 229
  year: 2020
  ident: 2015_CR26
  publication-title: Front Med.
  doi: 10.3389/fmed.2020.00229
  contributor:
    fullname: E Tantisattamo
– volume: 20
  start-page: 177
  year: 2015
  ident: 2015_CR1
  publication-title: Nephrology
  doi: 10.1111/nep.12378
  contributor:
    fullname: K Noppakun
– volume: 50
  start-page: 270
  year: 2009
  ident: 2015_CR27
  publication-title: Acta Radiol
  doi: 10.1080/02841850902718763
  contributor:
    fullname: G Hagen
– volume: 3
  start-page: e128
  issue: 2
  year: 2017
  ident: 2015_CR30
  publication-title: Transplant Direct
  doi: 10.1097/TXD.0000000000000643
  contributor:
    fullname: CC Estrada
– volume: 43
  start-page: 2205
  year: 2011
  ident: 2015_CR18
  publication-title: Transplant Proc
  doi: 10.1016/j.transproceed.2011.06.049
  contributor:
    fullname: M Marini
SSID ssj0017809
Score 2.3069162
Snippet Endovascular treatment is standard of care for transplant renal artery stenosis (TRAS). No study has evaluated long-term outcomes compared between percutaneous...
Abstract Background Endovascular treatment is standard of care for transplant renal artery stenosis (TRAS). No study has evaluated long-term outcomes compared...
Background Endovascular treatment is standard of care for transplant renal artery stenosis (TRAS). No study has evaluated long-term outcomes compared between...
BACKGROUNDEndovascular treatment is standard of care for transplant renal artery stenosis (TRAS). No study has evaluated long-term outcomes compared between...
Abstract Background Endovascular treatment is standard of care for transplant renal artery stenosis (TRAS). No study has evaluated long-term outcomes compared...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 212
SubjectTerms Adult
Anastomosis
Angioplasty
Angioplasty - adverse effects
Angioplasty - instrumentation
Antihypertensives
Bailouts
Blood & organ donations
Blood pressure
Cardiovascular system
Clinical trials
Databases, Factual
Epidermal growth factor receptors
Female
Glomerular filtration rate
Graft rejection
Grafts
Hospitals
Humans
Hypertension
Kidney transplantation
Kidney Transplantation - adverse effects
Kidney transplants
Long-term outcome
Male
Medical imaging
Medical records
Middle Aged
Patients
Percutaneous transluminal renal angioplasty (PTRA)
Percutaneous transluminal renal angioplasty with stenting (PTRAS)
Progression-Free Survival
Renal artery
Renal Artery Obstruction - diagnostic imaging
Renal Artery Obstruction - epidemiology
Renal Artery Obstruction - therapy
Renal failure
Restenosis
Retrospective Studies
Risk Assessment
Risk Factors
Stenosis
Stents
Success
Survival
Survival analysis
Thailand - epidemiology
Time Factors
Transplant renal artery stenosis (TRAS)
Veins & arteries
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gLAsojUJCROFAhq7Hj57EgqqqiCEEr9WbZjl32kqx2s4f-CP4z4zhZdRFSL71ESjyxnJmx_U1mPIPQB-GdaKlpCeeqITw2hjipKWGBNr4OTiuezzuff5enl_zsSlzdKvWVY8JKeuDCuKM6JiqjNFwkxoVxntHAgxeK1TFEXaBRbWZjavIfKF2b-YiMlkdrWIUVIzkcAeARFYTvbENjtv7_Qcx_IyVvbT0nT9DjCTPi4zLWp-hB7J6hh-eTV3wf_fnWd9ckr7G43wygQhH3CS_jKmwA-kWw7fGQtyRYh3INLLyK-eq660W_BPA83OCPPy5-Hh_iHKIBxPkG5x-0GFRgrCRRCH4d4kVXuoL3umHuKEeF3oy0_Xqxfo4uT75efDklU5kFEriRAxHAR98Ck1nwgBaCkzzViokgnTIuSa209zGbXoG2MTqvg06AA-sAApVCNC_QXtd38RXCVCSahKeuSY6bOprAk8o1_1rnJE2pQp9mrttlyaZhRytES1tkZEFGdpSR5RX6nAWzpcyZsMcHoB920g97l35U6GAWq52m59oywbQ2YFyoCr3fNsPEyt6SIhigobm0JgC4Cr0sWrAdSdOY7LKGFrWjHztD3W3pFr_H5N26Vkob9vo-vu0NesRGneaEyQO0N6w28S1gpMG_G6fDXwfREh4
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: AUTh Library subscriptions: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEBbtBkovpe-6TYsKPTQUEUvW81SSkhBKE0KaQG5GkqXNXuzt2nvIj8h_zsiPbbeUXgy2xmbkGY2-0Yw0CH0SzoqKmopwrgrCQ2GIlZoS5mnhcm-14mm_8-mZPLni36_F9bjg1o5plZNN7A111fi0Rr7PBNPaAB5UX5e_SKoalaKrYwmNh2iHgafAZmjn8Ojs_GITR1A6N9NWGS33W7DGipGUlgAwiQrCt6aj_tT-f0HNvzMm_5iCjp-iJyN2xAeDsJ-hB6F-jh6djtHxF-juR1PPSbK1uFl30K2Am4iXYeXXAAED-Pi4S1MT2KNUCwuvQrraer5olgCiu1v8-fzy4mAPp1QNIE43OC3UYlCFvqLEQPBzDy_q4VPwXt1NH0rZobc9bdMu2pfo6vjo8tsJGcstEM-N7IgIPriKysC8A9TgreQxV0x4aZWxUWqlnQvJBfO0CsE67XUEPJh7EKwUoniFZnVThzcIUxFpFI7aIlpu8mA8jyrV_quslTTGDH2Z_nq5HE7VKHtvRMtykFEJMip7GZU8Q4dJMBvKdCJ2_6BZzctxgJV5iMC6NFxExoWxjlHPvROK5dAvbTO0O4m1HIdpW_5Wqgx93DTDAEtRk0EwQENTiU0Achl6PWjBhpOiMCl0DS1qSz-2WN1uqRc3_SHeOldKG_b2_2y9Q49Zr62cMLmLZt1qHd4DCurch1HV7wGurgqo
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA_nCeKL-G31lAg-eEi0SfP5IHKKxyGeiN7CvZUkTdYFadduF9w_wv_ZST9WVxZfCm0mZZqZJL_pTGYQeiacFRU1FeFcFYSHwhArNSXM08Ll3mrF03nn80_ybMY_XIrLAzSVOxoHcLXXtEv1pGbt95c_f2zewIR_3U94LV-tYI1VjKRgAwA_VBB-BV1lKTFXCuXjf7wKSudmOjizt9_O5tTn8N8HPP-Nn_xrQzq9iW6MSBKfDKK_hQ5CfRtdOx995XfQr49NPSdp5cXNugPFCriJeBlavwZAGMDix13aqGB1SpWxcBvS1dbzRbMESN1t8PPPF19OjnEK3ADidIPTb1sMitHXlxgIvh7jRT28CvrV3fSiFCu66Wmb1WJ1F81O31-8OyNj8QXiuZEdEcEHV1EZmHeAIbyVPOaKCS-tMjZKrbRzIRlknlYhWKe9joAOcw9ilkIU99Bh3dThAcJURBqFo7aIlps8GM-jSpUAK2sljTFDL6ZRL5dDjo2yt020LAcZlSCjspdRyTP0NglmS5nyY_cPmnZejtOtzEME1qXhIjIujHWMeu6dUCyH79I2Q0eTWMtJ50ommNYGTA6VoafbZphuyYcyCAZoaCq4CbAuQ_cHLdhyUhQmObKhRe3oxw6ruy314luf0lvnSmnDHv6frUfoOuu1lRMmj9Bh167DY8BEnXvSK_pvFTgMXA
  priority: 102
  providerName: Scholars Portal
Title Long-term outcome of percutaneous transluminal renal angioplasty (PTRA) versus PTRA with stenting (PTRAS) in transplant renal artery stenosis
URI https://www.ncbi.nlm.nih.gov/pubmed/33902459
https://www.proquest.com/docview/2528898827
https://search.proquest.com/docview/2518989399
https://pubmed.ncbi.nlm.nih.gov/PMC8077892
https://doaj.org/article/0ef16e6945f2459ab21c4cb5720ece8a
Volume 21
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Na9swFBdtB2OXse9564IGO6wMN5asLx-b0lLGUkLWQtjFSIqUBVY7JM6hf8T-5z3JdmjGTrsIbD8J2e8n6fesp_cQ-sSN5nNSzFPGZJ4ylxepFoqk1JLcZFYrycJ55_G1uLplX2d8doB4fxYmOu1bszytft2dVsuf0bdydWeHvZ_YcDI-V5mUqqDDQ3QIAO1N9G7rQKqs6E_HKDHcwAQsaRo8EYAZEZ6GTDw5WPqUhfikDxajGLP_X0Tzb3_JBwvQ5TP0tGOO-Kzt4XN04KoX6PG42xt_iX5_q6tFGmZaXG8bAJLDtccrt7ZbIIAOLHzchIUJZqOQCQuvXSh1tVjWK6DQzT3-PLmZnp3g4KgBwuECh9-0GIAQ80m0At9P8LJqm4J6VdM3FHxD76NsvVluXqHby4ub86u0S7aQWlaIJuXOOjMnwlFrgDNYLZjPJOVWaFloL5RUxrhggFkyd04bZZUHNphZUKvgPH-Njqq6cm8RJtwTzw3RudesyFxhmZch899ca0G8T9CX_quXqzamRhltESXKVl0lqKuM6ipZgkZBMTvJEA873qjXi7JDRZk5D10XBeM-6FUbSiyzhkuawXspnaDjXq1lN0g3JeVUqQJMDJmgj7vHMLzCnkmrGJAhIcEm0LgEvWlRsOtJj6IEyT187HV1_wkgOobw7hD87r9rvkdPaMQ0S6k4RkfNeus-AD1qzAAGxUwO0KPRxfVkOog_GaAcMwXldPRjEIfLH8jgF5E
link.rule.ids 230,315,730,783,787,867,888,2109,12070,21402,24332,27938,27939,31733,31734,33758,33759,43324,43819,53806,53808
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lj9MwELZgkYAL4rkUFjASB1bI2tjx84QWxKpAu0LQlfZm2Y5deklKmx72R_Cf8SRpoQhxiZR4Eo0z4_E39ngGoVfCO1FRUxHOVUl4LA1xUlPCAi19EZxWHM47T8_l-IJ_uhSXw4Lbegir3NrEzlBXTYA18hMmmNYm40H1dvmDQNUo2F0dSmhcRzcgDxfkzleXO4eLKl2Y7UEZLU_W2RYrRiAoIYMkKgjfm4y6nP3_App_x0v-MQGd3UV3BuSIT3tR30PXYn0f3ZwOe-MP0M9JU88JWFrcbNrcqYibhJdxFTYZAMbs4eMWJqZsjaASFl5FuLp6vmiWGUK3V_j1l9nX02MMgRqZGG4wLNPirAhdPYme4NsxXtT9p_J7dbv9EMSGXnW0zXqxfoguzj7M3o_JUGyBBG5kS0QM0VdURhZ8xgzBSZ4KxUSQThmXpFba-wgOWKBVjM7roFNGg0XIYpVClI_QQd3U8THCVCSahKeuTI6bIprAk4LKf5VzkqY0Qm-2f90u-5watvNFtLS9jGyWke1kZPkIvQPB7CghH3b3oFnN7TC8bBFTZl0aLhLjwjjPaODBC8WK3C_tRuhoK1Y7DNK1_a1SI_Ry15yHF-yZ9ILJNBQKbGYYN0KHvRbsOClLAxvXuUXt6cceq_st9eJ7l8JbF0ppw578n60X6NZ4Np3Yycfzz0_RbdZpLidMHqGDdrWJzzIeav3zTul_AewLDDM
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagSBUX3pRAASNxoELZjR2_ciyFVYFutYJWqrhEtmMvK2iy2s0eyn_gPzPOY7VbceolUuKxZWs-29_E4xmE3nKjeUGyImZMpjFzaRZroUhMLUlNYrWSLNx3Hp-K43P25YJfbKT6apz2rZkNyt-Xg3L2s_GtnF_aYe8nNpyMj1QipcrocF744W10B-ZsonpDvTtAkCrJ-jsySgyXsAxLGgd_BOBHhMchH08K9j5lIUrpxpbURO7_H9287jW5sQ2N7qMf_QBa75Nfg1VtBvbPtdiONxrhA3SvI6f4sBV5iG658hHaHXfH74_R35OqnMZhMcfVqgasOlx5PHcLuwKO6arVEtdh74MFLyTbwgsXnrqczqo5sPT6Cr-bnH07PMDBFwSEwwsOf4IxYK1JWdEKfD_As7JtCuqVdd9QcD-9amSr5Wz5BJ2PPp0dHcddPofYskzUMXfWmYIIR60BWmK1YD6RlFuhZaa9UFIZ44KNZ0nhnDbKKg-EM7GAHMF5-hTtlFXpniFMuCeeG6JTr1mWuMwyL0NywUJrQbyP0Ptepfm8DduRN-aOEnmLhRywkDdYyFmEPgStryVDyO3mQ7WY5p1a8sR56LrIGPcBNNpQYpk1XNIExqV0hPZ7zOTdOrDMKadKZWDFyAi9WRfDDA7HMq1iQIaEHJ7AFCO010Js3ZMeohGSW-Db6up2CUCqiRLeQej5jWu-RruTj6P85PPp1xfoLm3mDoup2Ec79WLlXgIZq82rZtr9A6SGNrM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Long-term+outcome+of+percutaneous+transluminal+renal+angioplasty+%28PTRA%29+versus+PTRA+with+stenting+%28PTRAS%29+in+transplant+renal+artery+stenosis&rft.jtitle=BMC+cardiovascular+disorders&rft.au=Wongpraparut%2C+Nattawut&rft.au=Chaipruckmalakarn%2C+Thunyarat&rft.au=Tongdee%2C+Thongtum&rft.au=Jaspttananon%2C+Archan&rft.date=2021-04-26&rft.pub=BioMed+Central&rft.eissn=1471-2261&rft.volume=21&rft.spage=1&rft_id=info:doi/10.1186%2Fs12872-021-02015-4
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2261&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2261&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2261&client=summon